Mass Pharma is a subsidiary of the Khawaja Group and has been involved in the sale and marketing of pharmaceutical products since the last two decades. With the completion of its manufacturing facility during 1997, Mass Pharma has embarked on a journey of success and tremendous growth by producing quality pharmaceutical products for all. The strong will and determination of its pioneers coupled with the dedication and devotion of the experienced and professional management has played a major part in establishing its formulae for success.
Manufacturing highest quality products and marketing them at affordable prices to the ailing masses has always remained the prime mission of Mass Pharma. For this purpose, the company manufactures a diverse range of pharmaceutical products which include Antibiotics, NSAIDS, Antiulcerants, immuno-suppressant, dermatological and third generation cephalosporin parentral/oral formulations.
Mass Pharma’s manufacturing unit is a purpose built, environment friendly facility designed to meet long term goals and objectives. It is equipped with state of the art technology and employs highly qualified and experienced professionals in every department. Each and every step of the manufacturing process, from the receipt of raw materials to the delivery of finished product, is scrutinized by Quality Assurance Department. The company has achieved highest cGMP standards including ISO 9001:2008 certification. This is why one of the leading UK based multinational company continues to maintain its collaboration with Mass Pharma for the manufacturing of its dermatological and cardiovascular range.
Over the years, Mass Pharma has won several recognition awards which duly acknowledge its business success. However, the management does not exhibit any complacency due to receipt of such laurels but is really putting further endeavour to improve upon its achievements much further in the future.